Begin main content


Last Updated: June 8, 2016
Result type: Reports
Project Number: SR0500-000
Product Line: Common Drug Review

Generic Name: Edoxaban

Brand Name: Lixiana NVAF

Manufacturer: Daiichi Sankyo, Inc.

Indications: Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism

Submission Type: New

Project Status: Complete

Date Recommendation Issued: March 21, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions